Source:http://linkedlifedata.com/resource/pubmed/id/18321150
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-3-6
|
pubmed:abstractText |
1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1744-7623
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-94
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
Emerging drugs for malignant glioma.
|
pubmed:affiliation |
Princess Margaret Hospital, Department of Medicine, 610 University Avenue, Suite 18-717, Toronto, Ontario, M5G 2M9, Canada. warren.mason@uhn.on.ca
|
pubmed:publicationType |
Journal Article,
Review
|